Showing results (31-40 of 229) with videos related to

Sort By:
Pageof 23
Antimicrobial Agents and Chemotherapy|May 28, 2015
Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo ImagingAmanda Fortes Francisco, Michael D Lewis, Shiromani Jayawardhana, et al.
The Journal of Biological Chemistry|February 14, 2002
The Trypanosoma cruzi enzyme TcGPXI is a glycosomal peroxidase and can be linked to trypanothione reduction by glutathione or tryparedoxinShane R Wilkinson, David J Meyer, Martin C Taylor, et al.
Plos Neglected Tropical Diseases|March 21, 2020
Intracellular DNA replication and differentiation of Trypanosoma cruzi is asynchronous within individual host cells in vivo at all stages of infectionMartin C Taylor, Alexander Ward, Francisco Olmo, et al.
Molecules (Basel, Switzerland)|June 21, 2020
Challenges in Chagas Disease Drug DevelopmentAmanda F Francisco, Shiromani Jayawardhana, Francisco Olmo, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2025
Intermittent suppressive posaconazole therapy is ineffective at mitigating cardiac and digestive tract pathologies in an experimental model of chronic Chagas diseaseShiromani Jayawardhana, Francisco Olmo, Amanda Fortes Francisco, et al.
Plos Pathogens|November 13, 2023
Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in miceShiromani Jayawardhana, Alexander I Ward, Amanda F Francisco, et al.
Nucleic Acids Research|September 25, 2010
Centromere-associated topoisomerase activity in bloodstream form Trypanosoma bruceiSamson O Obado, Christopher Bot, Maria C Echeverry, et al.
Pageof 23